Guénette, Line <br/><br/>
Important treatment gaps in vascular protection for the elderly after type 2 diabetes therapy initiation.  [electronic resource] 

 -  The Canadian journal of cardiology  Dec 2013 
 - 1593-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1916-7075 
<br/><br/><label>Standard No.: </label>10.1016/j.cjca.2013.09.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Aged, 80 and over<br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Cardiovascular Diseases--prevention & control<br/>Cohort Studies<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Diabetic Angiopathies--prevention & control<br/>Drug Therapy, Combination<br/>Drug Utilization--statistics & numerical data<br/>Female<br/>Guideline Adherence<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Logistic Models<br/>Male<br/>Metformin--therapeutic use<br/>Multivariate Analysis<br/>Quebec<br/>Rural Population--statistics & numerical data<br/>Sulfonylurea Compounds--therapeutic use<br/>Urban Population--statistics & numerical data